Annals
Established in 1927 by the American College of Physicians
:
Advanced search
 
box Article
 arrow  Table of Contents                
space
 arrow  Full Text of this article Free
space
 arrow  Figures/Tables List
space
box Services
 arrow  Send comment/rapid response letter
space
 arrow  Notify a friend about this article
space
 arrow  Alert me when this article is cited
space
 arrow  Add to Personal Archive
space
 arrow  Download to Citation Manager
space
 arrow  ACP Search                        
space
 arrow  Get Permissions
space
box Google Scholar
 arrow  Search for Related Content
space
box PubMed
Articles in PubMed by Author:
  arrow  Hyman, F. N.
space
  arrow  Glinsmann, W. H.
space
 arrow  Related Articles in PubMed
space
 arrow  PubMed Citation
space
 arrow  PubMed
space

METHODS FOR VOLUNTARY WEIGHT LOSS AND CONTROL: NATIONAL INSTITUTES OF HEALTH TECHNOLOGY ASSESSMENT CONFERENCE

Evidence for Success of Caloric Restriction in Weight Loss and Control: Summary of Data from Industry

right arrow Frederick N. Hyman; Elena Sempos; Joyce Saltsman; and Walter H. Glinsmann

1 October 1993 | Volume 119 Issue 7 Part 2 | Pages 681-687

Data voluntarily supplied by industry were examined to evaluate the success of commercial weight loss programs and products. Information about the safe loss of weight, the maintenance of this lowered weight, and resultant health benefits were reviewed. Information was received from companies that produce over-the-counter preparations designed for persons with a small weight loss goal and from physician-supervised programs for morbidly obese persons placed on very-low-calorie diets. Regardless of the products used, successful weight loss and control was limited and required individualized programs consisting of restricted caloric intake, behavior modification, and exercise. Although some manufacturers of physician-supervised weight loss products for obese persons have defined the effectiveness of their programs with controlled clinical studies, other industry programs have only begun to accurately assess their effectiveness or safety. Given the importance to public health of reducing obesity, rigorous studies on current weight control practices should be pursued aggressively.

Author and Article Information
space

From the Food and Drug Administration and the Office of the Assistant Secretary for Health, Washington, DC.
Requests for Reprints: Frederick N. Hyman, DDS, MPH, Division of Nutrition, Food and Drug Administration, Washington, DC 20204.




This article has been cited by other articles:


Home page
ANN INTERN MEDHome page
A. G. Tsai and T. A. Wadden
Systematic Review: An Evaluation of Major Commercial Weight Loss Programs in the United States
Ann Intern Med, January 4, 2005; 142(1): 56 - 66.
[Abstract] [Full Text] [PDF]


Home page
Arch Fam MedHome page
J. Hauptman, C. Lucas, M. N. Boldrin, H. Collins, and K. R. Segal
Orlistat in the Long-term Treatment of Obesity in Primary Care Settings
Arch Fam Med, February 1, 2000; 9(2): 160 - 167.
[Abstract] [Full Text] [PDF]




 Home | Current Issue | Past Issues | In the Clinic | ACP Journal Club | CME | Collections | Audio/Video | Mobile | Subscribe | Tools | Help | ACP Online 

Copyright © 1993 by the American College of Physicians.